Register of
Medicinal Products

Product class: Authorized package
Medicinal product class: Veterinary medicine
Package code: 1212084
Name of medicinal product: Advocate täpilahus suurtele kassidele
Active substances:
Moxidectin+Imidacloprid
Estonian, English, Latin
ATC code: QP54AB81
Dosage form: spot-on solution
Route of administration: cutaneous use
Strengh: 10mg+100mg 1ml
Amount in package: 0.8ml 6TK
Legal status for supply*: Subject to medicinal prescription
Class of active substance:  
Additional information:  
Indication: For cats suffering from, or at risk from, mixed parasitic infections: • the treatment and prevention of flea infestation (Ctenocephalides felis), • the treatment of ear mite infestation (Otodectes cynotis), • the treatment of notoedric mange (Notoedres cati), • the treatment of the lungworm Eucoleus aerophilus (syn. Capillaria aerophila) (adults), • the prevention of lungworm disease (L3/L4 larvae of Aelurostrongylus abstrusus), • the treatment of the lungworm Aelurostrongylus abstrusus (adults), • the treatment of the eye worm Thelazia callipaeda (adults), • the prevention of heartworm disease (L3 and L4 larvae of Dirofilaria immitis), • the treatment of infections with gastrointestinal nematodes (L4 larvae, immature adults and adults of Toxocara cati and Ancylostoma tubaeforme). The product can be used as part of a treatment strategy for flea allergy dermatitis (FAD). For ferrets suffering from, or at risk from, mixed parasitic infections: • the treatment and prevention of flea infestation (Ctenocephalides felis), • the prevention of heartworm disease (L3 and L4 larvae of Dirofilaria immitis).
Safety features: No
Summary of product characteristics (SPC):
Package information leaflet (PIL): EST
Labelling:  
Withdrawal time: Ei rakendata.
Species: kass
Last imported to Estonia: Never imported to Estonia
Marketing authorization holder: Bayer Animal Health GmbH 
Marketing authorization number: EU/2/03/039 
Marketing authorization issued on: April 2, 2003 
Marketing authorization expires on: Unlimited 
Marketing authorization procedure type: Centralised 
Entry/Changing date: August 13, 2019
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription

You can download Acrobat Reader fromhere